Coronary Artery Bypass Surgery (CABG) Off or On Pump Revascularization Study
CORONARY
CABG Off or On Pump Revascularization Study (CORONARY)
1 other identifier
interventional
4,752
13 countries
52
Brief Summary
I. Main Research Question:
- To compare the risks and benefits of Off-pump Coronary artery bypass surgery (CABG) to On-pump CABG and to determine if one is better than the other.
- The purpose of this pilot study is also to see the rate of recruitment with expertise-based randomization across different hospital settings. II. Small RCT studies and meta-analyses done so far have not been able to conclusively say which of the procedure is better. A large randomized study is required to establish the risks and benefits associated with both the off-pump and on-pump CABG surgical procedures. III. The study will look at which of the two techniques reduce major risks associated with CABG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Oct 2007
Longer than P75 for phase_3
52 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 18, 2007
CompletedFirst Posted
Study publicly available on registry
April 20, 2007
CompletedStudy Start
First participant enrolled
October 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedSeptember 16, 2016
September 1, 2016
4.4 years
April 18, 2007
September 15, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
First Co-Primary Outcome
The occurrence of the composite of total mortality, stroke, nonfatal MI, or new renal failure at 30 days post CABG surgery
30 days post CABG surgery
Second co-primary outcome
The occurrence of the composite of total mortality, stroke, nonfatal MI, new renal failure, or repeat coronary revascularization (i.e. coronary artery bypass surgery or percutaneous coronary intervention) over 5 years after randomization.
5 years after CABG
Secondary Outcomes (2)
The assessment of total costs and resources consumption at 30 days after CABG surgery
30 days after CABG surgery
The assessment of total costs and resources consumption at 5 years after CABG surgery
5 years after CABG surgery
Study Arms (2)
On Pump Arm
ACTIVE COMPARATOROff Pump Arm
EXPERIMENTALInterventions
Coronary Artery Bypass Graft (CABG) using median sternotomy, CPB, cardioplegia and complete cross-clamp and no associated or concomitant surgical procedures
Coronary Artery Bypass Graft (CABG) with no associated or concomitant surgical procedures, using median sternotomy and without CPB and cardioplegia
Eligibility Criteria
You may qualify if:
- Patients who have been diagnosed with coronary artery disease (single, double or triple disease) will be eligible if they:
- require isolated CABG with median sternotomy
- are able to give their informed written consent
- are\> 21 years of age and
- have one or more of the following risk factors:
- ≥ 70 years
- peripheral vascular disease (previous peripheral bypass or amputation or ABI \<0.80)
- Cerebrovascular disease (history of stroke, TIA)
- Renal insufficiency (creatinine above upper limit of normal)
- \>60 years of age and one of the following:
- diabetes (oral hypoglycemic agent and/or insulin)
- urgent revascularization (waiting in hospital)
- LV ejection fraction \<35%
- current or recent smoker.
- years of age and two of the following:
- +4 more criteria
You may not qualify if:
- Patients will be excluded if they have one of the following:
- concomitant cardiac procedure associated with CABG,
- contra-indications to off-pump CABG or on-pump CABG (calcified aorta, intramuscular LAD, calcified coronaries, small target vessels)
- concomitant life-threatening disease likely to limit life expectancy to less than 2 years,
- prior enrollment in this trial
- emergency CABG surgery (immediate revascularization for hemodynamic instability) OR
- redo CABG.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Population Health Research Institutelead
- McMaster Universitycollaborator
- University of Oxfordcollaborator
- Instituto Dante Pazzanese de Cardiologiacollaborator
- Fu Wai Hospital, Beijing, Chinacollaborator
- Universidad de La Fronteracollaborator
- Fundación Cardiovascular de Colombiacollaborator
- Charles University, Czech Republiccollaborator
- Hopital Jean Minjozcollaborator
- Centre for Chronic Disease Control, Indiacollaborator
- Ospedale Santa Croce-Carle Cuneocollaborator
- Medical University of Gdanskcollaborator
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)collaborator
- Ankara Universitycollaborator
- Hotel Dieu Hospitalcollaborator
- Centre hospitalier de l'Université de Montréal (CHUM)collaborator
- SAL Hospital, Ahmedabad, Indiacollaborator
Study Sites (52)
Fundacion Medica de rio negro y neuquen
Rio Negro, Argentina
Beneficencia Portuguesa de Sao Paulo
São Paulo, CEP, 01323.001, Brazil
Instituto Dante Pazzanese de Cardiologia
São Paulo, CEP, 04012-909, Brazil
Hospital Sao Francisco Complexo Hospitalar Santa Casa
Porto Alegre, Rio Grande do Sul, 90020-090, Brazil
Irmande Santa Casa De Misericordia De Curtiba
Curitiba Parana, 80010030, Brazil
Braile Clinica de Servicos de Assistencia Medico
São José do Rio Preto, 15091-450, Brazil
Irmandade da Santa Casa de Misericordia de Sao Paulo
São Paulo, 01221-020, Brazil
Federal University of Sao Paulo School of Medicine
São Paulo, 04024-002, Brazil
Associação do Sanátorio Sírio
São Paulo, 04038-030, Brazil
Instituto do Coracao do Hospital das Clinicas da
São Paulo, 05403-00, Brazil
Hospital Mario Covas
São Paulo, 09190-615, Brazil
Santa Casa de Misericordia de Marilia
São Paulo, 17515-000, Brazil
Foothills Medical Centre
Calgary, Alberta, T2N 2T9, Canada
Hamilton General Hospital
Hamilton, Ontario, L8L 2X2, Canada
London Health Sciences Centre
London, Ontario, N6A 5A5, Canada
Toronto General Hospital
Toronto, Ontario, M5G 2C4, Canada
Montreal Heart Institute
Montreal, Quebec, H1T 1C8, Canada
Hotel-Dieu du CHUM
Montreal, Quebec, H2W 1T8, Canada
Hospital Regional Temuco
Temuco, Región de la Araucanía, Chile
Instituto Nacional del Torax
Santiago, Chile
ChaoYang Hospital
Beijing, China
FuWai Hospital
Beijing, China
Nanjing First Hospital
Nanjing, China
Fundacion Cardioinfantil
Bogotá, Colombia
Fundacion Valle Del Lili
Cali, Colombia
Charles University Hospital
Hradec Králové, 50005, Czechia
Kardiochirurgicke centrum
Ostrava-Poruba, 708 52, Czechia
University Hospital Pilsen
Pilsen, 304 60, Czechia
Fakultni nemocnice Kralovske Vinohrady (FNKV)
Prague, 100 34, Czechia
University Hospital Motol
Prague, 150 00, Czechia
Nemocnice Podlesi
Třinec, 739 61, Czechia
Service de chirurgie thoracique et cardio-vasculaire
Besançon, 25030, France
Nizam's Institute of Medical Sciences
Hyderabad, Andhra Pradesh, 500 082, India
SAL Hospital and Medical Institute
Ahmedabad, Gujarat, 380054, India
Amrita Institute of Medical Sciences and Research Center
Kochi, Kerala, 682 026, India
G.Kuppuswamy Naidu Memorial Hospital
Coimbatore, Tamil Nadu, 641 037, India
SAL Hospital
Ahmedabad, India
International Center of Cardiovascular and Thoracic Diseases
Chennai Tamil Nadu, 600101, India
Sanjay Gandhi PGIMS
Lucknow, 226 014, India
All India Institute of Medical Sciences
New Delhi, 110016, India
Escorts Heart Institute and Research Centre
Noida, 201307, India
Ospedale S. Croce
Cuneo, 12100, Italy
Ospedale Niguarda - Ca Granda
Milan, 20162, Italy
Jagiellonian University
Krakow, 31-202, Poland
Alp Aslan
Ankara, Turkey (Türkiye)
Erol Senor
Ankara, Turkey (Türkiye)
Ruchan Akar
Ankara, Turkey (Türkiye)
Sertap Aykut Aka
Ankara, Turkey (Türkiye)
Volkan Sinci
Ankara, Turkey (Türkiye)
Basildon and Thurrock University Hospital NHS FT
Basildon, Essex, SS16 5NL, United Kingdom
Royal Infirmary of Edinburgh
Edinburgh, EU, 16 4SU, United Kingdom
The John Radcliffe Hospital
Oxford, OX3 9DU, United Kingdom
Related Publications (10)
Dimagli A, Gaudino M, An KR, Olaria RP, Soletti GJ, Cancelli G, Harik L, Noiseux N, Stevens LM, Lamy A; CORONARY investigators. Five-Year Hospital Readmission After Coronary Artery Bypass Surgery and the Association With Off-Pump Surgery and Sex. J Am Heart Assoc. 2023 Apr 18;12(8):e028063. doi: 10.1161/JAHA.122.028063. Epub 2023 Apr 7.
PMID: 37026546DERIVEDHebert M, Lamy A, Noiseux N, Stevens LM; CORONARY Investigators. Impact of early quantitative morbidity on 1-year outcomes in coronary artery bypass graft surgery. Interact Cardiovasc Thorac Surg. 2022 Mar 31;34(4):523-531. doi: 10.1093/icvts/ivab316.
PMID: 34788466DERIVEDConen D, Wang MK, Devereaux PJ, Whitlock R, McIntyre WF, Healey JS, Yuan F, Yusuf S, Lamy A. New-Onset Perioperative Atrial Fibrillation After Coronary Artery Bypass Grafting and Long-Term Risk of Adverse Events: An Analysis From the CORONARY Trial. J Am Heart Assoc. 2021 Jun 15;10(12):e020426. doi: 10.1161/JAHA.120.020426. Epub 2021 May 29.
PMID: 34056913DERIVEDLamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Straka Z, Piegas LS, Avezum A, Akar AR, Lanas Zanetti F, Jain AR, Noiseux N, Padmanabhan C, Bahamondes JC, Novick RJ, Tao L, Olavegogeascoechea PA, Airan B, Sulling TA, Whitlock RP, Ou Y, Gao P, Pettit S, Yusuf S; CORONARY Investigators. Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting. N Engl J Med. 2016 Dec 15;375(24):2359-2368. doi: 10.1056/NEJMoa1601564. Epub 2016 Oct 23.
PMID: 27771985DERIVEDLamy A, Tong W, Devereaux PJ, Gao P, Gafni A, Singh K, Taggart D, Straka Z, Akar AR, Piegas L, Ou Y, Yusuf S. The cost implications of off-pump versus on-pump coronary artery bypass graft surgery at one year. Ann Thorac Surg. 2014 Nov;98(5):1620-5. doi: 10.1016/j.athoracsur.2014.06.046. Epub 2014 Sep 24.
PMID: 25261272DERIVEDGarg AX, Devereaux PJ, Yusuf S, Cuerden MS, Parikh CR, Coca SG, Walsh M, Novick R, Cook RJ, Jain AR, Pan X, Noiseux N, Vik K, Stolf NA, Ritchie A, Favaloro RR, Parvathaneni S, Whitlock RP, Ou Y, Lawrence M, Lamy A; CORONARY Investigators. Kidney function after off-pump or on-pump coronary artery bypass graft surgery: a randomized clinical trial. JAMA. 2014 Jun 4;311(21):2191-8. doi: 10.1001/jama.2014.4952.
PMID: 24886787DERIVEDLamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, Straka Z, Piegas LS, Akar AR, Jain AR, Noiseux N, Padmanabhan C, Bahamondes JC, Novick RJ, Vaijyanath P, Reddy SK, Tao L, Olavegogeascoechea PA, Airan B, Sulling TA, Whitlock RP, Ou Y, Pogue J, Chrolavicius S, Yusuf S; CORONARY Investigators. Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med. 2013 Mar 28;368(13):1179-88. doi: 10.1056/NEJMoa1301228. Epub 2013 Mar 11.
PMID: 23477676DERIVEDGarg AX, Devereaux PJ, Yusuf S, Cuerden MS, Parikh CR, Coca SG, Walsh M, Cook RJ, Whitlock RP, Noiseux N, Novick RJ, Ou Y, Lamy A; CORONARY Investigators. Coronary Artery Bypass Grafting Surgery Off- or On-pump Revascularisation Study (CORONARY): kidney substudy analytic protocol of an international randomised controlled trial. BMJ Open. 2012 Apr 18;2(2):e001080. doi: 10.1136/bmjopen-2012-001080. Print 2012.
PMID: 22514244DERIVEDLamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, Straka Z, Piegas LS, Akar AR, Jain AR, Noiseux N, Padmanabhan C, Bahamondes JC, Novick RJ, Vaijyanath P, Reddy S, Tao L, Olavegogeascoechea PA, Airan B, Sulling TA, Whitlock RP, Ou Y, Ng J, Chrolavicius S, Yusuf S; CORONARY Investigators. Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med. 2012 Apr 19;366(16):1489-97. doi: 10.1056/NEJMoa1200388. Epub 2012 Mar 26.
PMID: 22449296DERIVEDLamy A, Devereaux PJ, Prabhakaran D, Hu S, Piegas LS, Straka Z, Paolasso E, Taggart D, Lanas F, Akar AR, Jain A, Noiseux N, Ou Y, Chrolavicius S, Ng J, Yusuf S. Rationale and design of the coronary artery bypass grafting surgery off or on pump revascularization study: a large international randomized trial in cardiac surgery. Am Heart J. 2012 Jan;163(1):1-6. doi: 10.1016/j.ahj.2011.10.007.
PMID: 22172429DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lamy Andre, MD, MSc
McMaster University
- PRINCIPAL INVESTIGATOR
Salim Yusuf, MD, DPhil
Population Health Research Institute
- PRINCIPAL INVESTIGATOR
David Taggart, MD
University of Oxford
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Cardiac Surgeon
Study Record Dates
First Submitted
April 18, 2007
First Posted
April 20, 2007
Study Start
October 1, 2007
Primary Completion
March 1, 2012
Study Completion
September 1, 2016
Last Updated
September 16, 2016
Record last verified: 2016-09